High Prevalence of Multi-Drug Resistance and Extended-Spectrum Beta-Lactamase-Producing Among Hospitalized Patients Presumptive for Bacterial Infection at Debre Berhan Comprehensive Specialized Hospital, Ethiopia

Overview

Journal Infect Drug Resist

Publisher Dove Medical Press

Date 2022 Jun 1

PMID 35642212

Authors

Zenawork Sahle

Getabalew Engidaye

Demissew Shenkute

Yeshi Metaferia

Agumas Shibabaw

Affiliations

Soon will be listed here.

Abstract

Background: Multi-drug resistant (MDR-E), primarily extended-spectrum beta-lactamase producers (ESBLs), have emerged as a major public health concern. This study aimed to determine the prevalence of multi-drug resistance and extended-spectrum beta-lactamase-producing among hospitalized patients presumptive for bacterial infections at Debre Berhan Comprehensive Specialized Hospital, Ethiopia.

Methods: A hospital-based cross-sectional study was conducted from January to May 2021. A total of 384 hospitalized patients presumptive for bacterial infections were included in the study. Urine, wound, blood, stool, and sputum samples were collected and cultured on MacConkey agar, Cysteine Lactose Electrolyte Deficient medium, and Blood agar. Identification was done using a panel of biochemical tests. The antimicrobial susceptibility test was done by disc diffusion. Screening of ESBL production was done by using cefotaxime and ceftazidime and confirmed by the combination disk method per clinical laboratory standard institute guidelines. Data analysis was performed by Statistical Package for Social Sciences software version 25, and a P-value ≤0.05 was considered as statistically significant.

Results: Out of 384 study participants, a total of 164 were isolated. The overall multi-drug resistance rate (MDR) was 92.1%. The overall prevalence of ESBL-PE was 104 (63.4%). 50 (30.5%) and 24 (14.6%) were the predominant ESBL producers. The highest ESBL producers (13.4%) and (6.1%) were isolated from urine sample. History of antibiotic use for the last three months (P-value=0.01), admission in neonatal intensive care unit (P-value=0.02), history of hospital stays (P-value=0.01), and chronic disease (P-value=0.04) showed statistically significant association with ESBL-PE infection.

Conclusion: The prevalence of MDR-E and ESBL-PE was high. Therefore, strong infection prevention and control measures and careful selection of antibiotics are needed in the study area to block the transmission and infection in the healthcare setting.

Citing Articles

Bacterial foodborne illness and O157:H7 strain infection among asymptomatic food handlers in Northeast Ethiopia: Implication for hygienic practices and mass-screening.

Adefrash K, Sharew B, Amare W, Shibabaw A Health Sci Rep. 2024; 7(6):e2199.

PMID: 38895551 PMC: 11183919. DOI: 10.1002/hsr2.2199.

Prevalence of phenotypic multi-drug resistant Klebsiella species recovered from different human specimens in Ethiopia: A systematic review and meta-analysis.

Kijineh B, Alemeyhu T, Mengistu M, Ali M PLoS One. 2024; 19(2):e0297407.

PMID: 38335186 PMC: 10857728. DOI: 10.1371/journal.pone.0297407.

Evaluation of three protocols for direct susceptibility testing for gram negative-Enterobacteriaceae from patient samples in Uganda with SMS reporting.

Aruhomukama D, Magiidu W, Katende G, Ebwongu R, Bulafu D, Kasolo R Sci Rep. 2024; 14(1):2730.

PMID: 38302620 PMC: 10834995. DOI: 10.1038/s41598-024-53230-w.

References

Rawat D, Nair D . Extended-spectrum β-lactamases in Gram Negative Bacteria. J Glob Infect Dis. 2010; 2(3):263-74. PMC: 2946684. DOI: 10.4103/0974-777X.68531. View

Moges F, Mengistu G, Genetu A . Multiple drug resistance in urinary pathogens at Gondar College of Medical Sciences Hospital, Ethiopia. East Afr Med J. 2003; 79(8):415-9. DOI: 10.4314/eamj.v79i8.8827. View

Legese M, Weldearegay G, Asrat D . Extended-spectrum beta-lactamase- and carbapenemase-producing among Ethiopian children. Infect Drug Resist. 2017; 10:27-34. PMC: 5279835. DOI: 10.2147/IDR.S127177. View

Teklu D, Negeri A, Legese M, Legesse Bedada T, Woldemariam H, Tullu K . Extended-spectrum beta-lactamase production and multi-drug resistance among isolated in Addis Ababa, Ethiopia. Antimicrob Resist Infect Control. 2019; 8:39. PMC: 6377715. DOI: 10.1186/s13756-019-0488-4. View

Mulu W, Abera B, Yimer M, Hailu T, Ayele H, Abate D . Bacterial agents and antibiotic resistance profiles of infections from different sites that occurred among patients at Debre Markos Referral Hospital, Ethiopia: a cross-sectional study. BMC Res Notes. 2017; 10(1):254. PMC: 5501330. DOI: 10.1186/s13104-017-2584-y. View

Nordmann P, Dortet L, Poirel L . Carbapenem resistance in Enterobacteriaceae: here is the storm!. Trends Mol Med. 2012; 18(5):263-72. DOI: 10.1016/j.molmed.2012.03.003. View

Andrew B, Kagirita A, Bazira J . Prevalence of Extended-Spectrum Beta-Lactamases-Producing Microorganisms in Patients Admitted at KRRH, Southwestern Uganda. Int J Microbiol. 2017; 2017:3183076. PMC: 5320295. DOI: 10.1155/2017/3183076. View

Ruh E, Zakka J, Hoti K, Fekrat A, Guler E, Gazi U . Extended-spectrum β-lactamase, plasmid-mediated AmpC β-lactamase, fluoroquinolone resistance, and decreased susceptibility to carbapenems in : fecal carriage rates and associated risk factors in the community of Northern Cyprus. Antimicrob Resist Infect Control. 2019; 8:98. PMC: 6558775. DOI: 10.1186/s13756-019-0548-9. View

Medboua-Benbalagh C, Touati A, Kermas R, Gharout-Sait A, Brasme L, Mezhoud H . Fecal Carriage of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Strains Is Associated with Worse Outcome in Patients Hospitalized in the Pediatric Oncology Unit of Beni-Messous Hospital in Algiers, Algeria. Microb Drug Resist. 2017; 23(6):757-763. DOI: 10.1089/mdr.2016.0153. View

10.

Schwaber M, Navon-Venezia S, Schwartz D, Carmeli Y . High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2005; 49(5):2137-9. PMC: 1087677. DOI: 10.1128/AAC.49.5.2137-2139.2005. View

11.

Babu R, Kumar A, Karim S, Warrier S, Nair S, Singh S . Faecal carriage rate of extended-spectrum β-lactamase-producing Enterobacteriaceae in hospitalised patients and healthy asymptomatic individuals coming for health check-up. J Glob Antimicrob Resist. 2016; 6:150-153. DOI: 10.1016/j.jgar.2016.05.007. View

12.

Dagnew M, Yismaw G, Gizachew M, Gadisa A, Abebe T, Tadesse T . Bacterial profile and antimicrobial susceptibility pattern in septicemia suspected patients attending Gondar University Hospital, Northwest Ethiopia. BMC Res Notes. 2013; 6:283. PMC: 3723433. DOI: 10.1186/1756-0500-6-283. View

13.

Arhoune B, Oumokhtar B, Hmami F, Barguigua A, Timinouni M, El Fakir S . Rectal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae among hospitalised neonates in a neonatal intensive care unit in Fez, Morocco. J Glob Antimicrob Resist. 2017; 8:90-96. DOI: 10.1016/j.jgar.2016.11.004. View

14.

Aklilu A, Manilal A, Ameya G, Woldemariam M, Siraj M . Gastrointestinal Tract Colonization Rate of Extended-Spectrum Beta-Lactamase- and Carbapenemase-Producing Enterobacteriaceae and Associated Factors Among Hospitalized Patients in Arba Minch General Hospital, Arba Minch, Ethiopia. Infect Drug Resist. 2020; 13:1517-1526. PMC: 7250175. DOI: 10.2147/IDR.S239092. View

15.

Tekele S, Teklu D, Tullu K, Birru S, Legese M . Extended-spectrum Beta-lactamase and AmpC beta-lactamases producing gram negative bacilli isolated from clinical specimens at International Clinical Laboratories, Addis Ababa, Ethiopia. PLoS One. 2020; 15(11):e0241984. PMC: 7660541. DOI: 10.1371/journal.pone.0241984. View

16.

Seni J, Sweya E, Mabewa A, Mshana S, Gilyoma J . Comparison of antimicrobial resistance patterns of ESBL and non ESBL bacterial isolates among patients with secondary peritonitis at Bugando Medical Centre, Mwanza - Tanzania. BMC Emerg Med. 2016; 16(1):41. PMC: 5073734. DOI: 10.1186/s12873-016-0106-1. View

17.

Eshetie S, Unakal C, Gelaw A, Ayelign B, Endris M, Moges F . Multidrug resistant and carbapenemase producing Enterobacteriaceae among patients with urinary tract infection at referral Hospital, Northwest Ethiopia. Antimicrob Resist Infect Control. 2015; 4:12. PMC: 4407313. DOI: 10.1186/s13756-015-0054-7. View

18.

Bayleyegn B, Fisaha R, Kasew D . Fecal carriage of extended spectrum beta-lactamase producing Enterobacteriaceae among HIV infected children at the University of Gondar Comprehensive Specialized Hospital Gondar, Ethiopia. AIDS Res Ther. 2021; 18(1):19. PMC: 8061171. DOI: 10.1186/s12981-021-00347-x. View

19.

Kariuki S, Dougan G . Antibacterial resistance in sub-Saharan Africa: an underestimated emergency. Ann N Y Acad Sci. 2014; 1323:43-55. PMC: 4159419. DOI: 10.1111/nyas.12380. View

20.

Kibret M, Abera B . Antimicrobial susceptibility patterns of E. coli from clinical sources in northeast Ethiopia. Afr Health Sci. 2011; 11 Suppl 1:S40-5. PMC: 3220125. DOI: 10.4314/ahs.v11i3.70069. View